Cargando…
Venlafaxine-induced psychotic symptoms
Venlafaxine, an antidepressant belongs to Serotonin Norepinephrine Reuptake Inhibitors (SNRI), blocks the synaptic reuptake of serotonin in lower doses and also blocks reuptake of norepinephrine in higher doses. In addition it also blocks dopamine reuptake in still higher doses. This last mechanism...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802382/ https://www.ncbi.nlm.nih.gov/pubmed/20048460 http://dx.doi.org/10.4103/0019-5545.58301 |
_version_ | 1782175993726763008 |
---|---|
author | Safeekh, A. T. Pinto, Denzil |
author_facet | Safeekh, A. T. Pinto, Denzil |
author_sort | Safeekh, A. T. |
collection | PubMed |
description | Venlafaxine, an antidepressant belongs to Serotonin Norepinephrine Reuptake Inhibitors (SNRI), blocks the synaptic reuptake of serotonin in lower doses and also blocks reuptake of norepinephrine in higher doses. In addition it also blocks dopamine reuptake in still higher doses. This last mechanism of action is found to cause psychotic symptoms. Very few cases are reported with this adverse effect of venlafaxine. Here is a case report where a 32 year-old male with social phobia developed delusions of persecution on two occasions when he was put on venlafaxine 150 mg/day, which responded to withdrawal of venlafaxine and a short course of antipsychotics. The delusions never reappeared when he was maintained on escitalopram. |
format | Text |
id | pubmed-2802382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-28023822010-01-14 Venlafaxine-induced psychotic symptoms Safeekh, A. T. Pinto, Denzil Indian J Psychiatry Case Report Venlafaxine, an antidepressant belongs to Serotonin Norepinephrine Reuptake Inhibitors (SNRI), blocks the synaptic reuptake of serotonin in lower doses and also blocks reuptake of norepinephrine in higher doses. In addition it also blocks dopamine reuptake in still higher doses. This last mechanism of action is found to cause psychotic symptoms. Very few cases are reported with this adverse effect of venlafaxine. Here is a case report where a 32 year-old male with social phobia developed delusions of persecution on two occasions when he was put on venlafaxine 150 mg/day, which responded to withdrawal of venlafaxine and a short course of antipsychotics. The delusions never reappeared when he was maintained on escitalopram. Medknow Publications 2009 /pmc/articles/PMC2802382/ /pubmed/20048460 http://dx.doi.org/10.4103/0019-5545.58301 Text en © Indian Journal of Psychiatry http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Safeekh, A. T. Pinto, Denzil Venlafaxine-induced psychotic symptoms |
title | Venlafaxine-induced psychotic symptoms |
title_full | Venlafaxine-induced psychotic symptoms |
title_fullStr | Venlafaxine-induced psychotic symptoms |
title_full_unstemmed | Venlafaxine-induced psychotic symptoms |
title_short | Venlafaxine-induced psychotic symptoms |
title_sort | venlafaxine-induced psychotic symptoms |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802382/ https://www.ncbi.nlm.nih.gov/pubmed/20048460 http://dx.doi.org/10.4103/0019-5545.58301 |
work_keys_str_mv | AT safeekhat venlafaxineinducedpsychoticsymptoms AT pintodenzil venlafaxineinducedpsychoticsymptoms |